Actively Recruiting
Ropeginterferon Alfa-2b in Patients With Polycythemia Vera (PV) Without Symptomatic Splenomegaly
Led by iOMEDICO AG · Updated on 2026-01-09
200
Participants Needed
1
Research Sites
238 weeks
Total Duration
On this page
Sponsors
I
iOMEDICO AG
Lead Sponsor
A
AOP Orphan Pharmaceuticals Germany GmbH
Collaborating Sponsor
AI-Summary
What this Trial Is About
The primary objective of this non interventional study is to evaluate symptom burden in adult patients with PV without symptomatic splenomegaly during treatment with ropeginterferon alfa-2b in a real-world setting. Further patient-relevant endpoints include effectiveness including complete hematologic response (CHR), event-free survival (EFS), safety and tolerability, treatment reality including dosing details as well as factors affecting treatment decision making.
CONDITIONS
Official Title
Ropeginterferon Alfa-2b in Patients With Polycythemia Vera (PV) Without Symptomatic Splenomegaly
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 2 years or older
- Confirmed diagnosis of polycythemia vera without symptomatic splenomegaly
- Indicated for treatment with ropeginterferon alfa-2b according to current product guidelines
- No prior treatment with ropeginterferon alfa-2b, but enrollment allowed up to 6 weeks after first dose if still on treatment
- Signed informed consent form dated
- Willingness to participate in German-language patient-reported outcome assessments and complete questionnaires at enrollment
- Other criteria as per current product guidelines
You will not qualify if you...
- Participation in another interventional clinical trial (except follow-up studies)
- Any contraindications listed in the current product guidelines for ropeginterferon alfa-2b
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Onkologisches Studienzentrum Dr. med. Ingo Zander & Dr. med. Eyck von der Heyde
Hanover, Lower Saxony, Germany, 30161
Actively Recruiting
Research Team
L
Laura Serrer
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here